Author Index: S
• GLOBETROTTING - EXPLORING INTERNATIONAL CAREER PATHS
• MENTORING MEET-AND-GREET
• ESTIMATING THE HEALTHCARE COSTS ATTRIBUTABLE TO INVASIVE MENINGOCOCCAL DISEASE
• THE ECONOMIC IMPACT OF CLOSTRIDIUM DIFFICILE: A SYSTEMATIC REVIEW
• ADOPTING THE PHASE-OF-CARE APPROACH TO ESTIMATE COSTS OF A SECONDARY DIAGNOSIS OF CLOSTRIDIUM DIFFICILE
• MENTORING MEET-AND-GREET
• ESTIMATING THE HEALTHCARE COSTS ATTRIBUTABLE TO INVASIVE MENINGOCOCCAL DISEASE
• THE ECONOMIC IMPACT OF CLOSTRIDIUM DIFFICILE: A SYSTEMATIC REVIEW
• ADOPTING THE PHASE-OF-CARE APPROACH TO ESTIMATE COSTS OF A SECONDARY DIAGNOSIS OF CLOSTRIDIUM DIFFICILE
• MODELING THE COST EFFECTIVENESS OF NEUROIMAGING-BASED TREATMENT OF ACUTE STROKE PATIENTS WITH UNKNOWN STROKE ONSET TIME
• THE COST-EFFECTIVENESS OF TARGETING HIV PRE-EXPOSURE PROPHYLAXIS BASED ON PARTNER TREATMENT STATUS IN MEN WHO HAVE SEX WITH MEN IN THE US
• COST-EFFECTIVENESS ANALYSIS OF CYP2B6 GENETIC TESTING TO INFORM EFAVIRENZ DOSE REDUCTION FOR INITIAL HIV THERAPY
• THE COST-EFFECTIVENESS OF TARGETING HIV PRE-EXPOSURE PROPHYLAXIS BASED ON PARTNER TREATMENT STATUS IN MEN WHO HAVE SEX WITH MEN IN THE US
• COST-EFFECTIVENESS ANALYSIS OF CYP2B6 GENETIC TESTING TO INFORM EFAVIRENZ DOSE REDUCTION FOR INITIAL HIV THERAPY
• PRE-MEETING DESSERT SYMPOSIUM - LUNG CANCER SCREENING: A DEBATE OF SCIENCE, ETHICS & POLICY (NCI R13)
• INSIGHTS FROM FUNDING AGENCIES
• TAILORING, EXEMPLARS, AND AMOUNT OF INFORMATION IN AN ONLINE MAMMOGRAPHY DECISION AID: EFFECTS ON DECISION PROCESS OUTCOMES
• DEVELOPMENT OF THE PERCEIVED VALUE OF SCIENTIFIC EVIDENCE IN HEALTH (VSE-H) SCALE
• INSIGHTS FROM FUNDING AGENCIES
• TAILORING, EXEMPLARS, AND AMOUNT OF INFORMATION IN AN ONLINE MAMMOGRAPHY DECISION AID: EFFECTS ON DECISION PROCESS OUTCOMES
• DEVELOPMENT OF THE PERCEIVED VALUE OF SCIENTIFIC EVIDENCE IN HEALTH (VSE-H) SCALE
• QUANTIFYING THE DISUTILITY OF TAKING PILLS FOR PREVENTING HEART DISEASE
• TESTING A COLORECTAL CANCER SCREENING DECISION AID TARGETED TO OLDER ADULTS
• STRENGTH OF EVIDENCE FOR STRATEGIES USED TO DISSEMINATE MEDICAL EVIDENCE TO CLINICIANS AND PATIENTS
• WHICH COMMUNICATION STRATEGIES IMPACT THE EFFECTIVENESS OF MESSAGES ABOUT MEDICAL EVIDENCE?
• TESTING A COLORECTAL CANCER SCREENING DECISION AID TARGETED TO OLDER ADULTS
• STRENGTH OF EVIDENCE FOR STRATEGIES USED TO DISSEMINATE MEDICAL EVIDENCE TO CLINICIANS AND PATIENTS
• WHICH COMMUNICATION STRATEGIES IMPACT THE EFFECTIVENESS OF MESSAGES ABOUT MEDICAL EVIDENCE?
• WHEN IS ENOUGH EVIDENCE ENOUGH? VALUE-OF-INFORMATION ANALYSIS FOR PRIORITIZING ADDITIONAL OUTCOMES RESEARCH ON THE TREATMENT OF CHRONIC MYELOID LEUKEMIA
• THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL - LESSONS LEARNED FROM NATURAL HISTORY CALIBRATION
• COST-EFFECTIVENESS OF THE SEQUENTIAL APPLICATION OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA PATIENTS IN THE UNITED STATES
• SMDM CORE COURSE: INTRODUCTION TO MEDICAL DECISION ANALYSIS (DECISION-ANALYTIC MODELING)
• *TOP RANKED ABSTRACT AT THE 15TH BIENNIAL EUROPEAN MEETING* COMBINING MARKOV STATES: A COMPARISON OF ANALYTICAL AND HEURISTIC METHODS FOR DERIVING THE HAZARD RATES OF A COLLAPSED MARKOV STATE
• THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL - LESSONS LEARNED FROM NATURAL HISTORY CALIBRATION
• COST-EFFECTIVENESS OF THE SEQUENTIAL APPLICATION OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA PATIENTS IN THE UNITED STATES
• SMDM CORE COURSE: INTRODUCTION TO MEDICAL DECISION ANALYSIS (DECISION-ANALYTIC MODELING)
• *TOP RANKED ABSTRACT AT THE 15TH BIENNIAL EUROPEAN MEETING* COMBINING MARKOV STATES: A COMPARISON OF ANALYTICAL AND HEURISTIC METHODS FOR DERIVING THE HAZARD RATES OF A COLLAPSED MARKOV STATE
• RAPID ASSESSMENT OF MODELLING SOFTWARE BY END-USERS: THE EXAMPLE OF GLYCEMIC MANAGEMENT OPTIONS FOR TYPE 2 DIABETES
• ESTIMATED HEALTH AND ECONOMIC IMPACT OF IMMUNIZATION AGAINST VACCINE-PREVENTABLE DISEASES RELATED TO TEN ANTIGENS IN 73 COUNTRIES DURING THE DECADE OF VACCINES (2011-2020)
• ESTIMATING THE IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINES IN RESOURCE-POOR SETTINGS: A PORTABLE HEALTH POLICY MODEL FOR NEW VACCINE INTRODUCTION
• ESTIMATED HEALTH AND ECONOMIC IMPACT OF IMMUNIZATION AGAINST VACCINE-PREVENTABLE DISEASES RELATED TO TEN ANTIGENS IN 73 COUNTRIES DURING THE DECADE OF VACCINES (2011-2020)
• ESTIMATING THE IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINES IN RESOURCE-POOR SETTINGS: A PORTABLE HEALTH POLICY MODEL FOR NEW VACCINE INTRODUCTION
• COST-EFFECTIVENESS OF NOVEL HEPATITIS C REGIMENS IN THE VETERANS HEALTH ADMINISTRATION
• UNIVERSAL BACILLE CALMETTE-GUERIN (BCG) VACCINATION IN ECUADOR: A COST EFFECTIVENESS ANALYSIS
• PROMOTING ORGAN DONOR REGISTRIES THROUGH PUBLIC EDUCATION CAMPAIGNS: WHAT IS THE COST OF SECURING FUTURE ORGAN DONORS?
• UNIVERSAL BACILLE CALMETTE-GUERIN (BCG) VACCINATION IN ECUADOR: A COST EFFECTIVENESS ANALYSIS
• PROMOTING ORGAN DONOR REGISTRIES THROUGH PUBLIC EDUCATION CAMPAIGNS: WHAT IS THE COST OF SECURING FUTURE ORGAN DONORS?
• THE IMPACT OF HEALTH INFORMATION TECHNOLOGY IMPLEMENTATION ON STAFFING PATTERNS AND COSTS
• THE CLINICAL, PSYCHO-SOCIAL AND COST IMPACTS OF PERFORMING ACTIVE SURVEILLANCE ON KNOWN MRSA+ PATIENTS ADMITTED TO MEDICAL-SURGICAL UNITS
• TRANSLATING KNOWLEDGE INTO POLICY: THE CASE OF VALUE BASED INSURANCE DESIGN
• THE CLINICAL, PSYCHO-SOCIAL AND COST IMPACTS OF PERFORMING ACTIVE SURVEILLANCE ON KNOWN MRSA+ PATIENTS ADMITTED TO MEDICAL-SURGICAL UNITS
• TRANSLATING KNOWLEDGE INTO POLICY: THE CASE OF VALUE BASED INSURANCE DESIGN
• THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL - LESSONS LEARNED FROM NATURAL HISTORY CALIBRATION
• *TOP RANKED ABSTRACT AT THE 15TH BIENNIAL EUROPEAN MEETING* COMBINING MARKOV STATES: A COMPARISON OF ANALYTICAL AND HEURISTIC METHODS FOR DERIVING THE HAZARD RATES OF A COLLAPSED MARKOV STATE
• *TOP RANKED ABSTRACT AT THE 15TH BIENNIAL EUROPEAN MEETING* COMBINING MARKOV STATES: A COMPARISON OF ANALYTICAL AND HEURISTIC METHODS FOR DERIVING THE HAZARD RATES OF A COLLAPSED MARKOV STATE
• USING A WEB-BASED PATIENT REPORTED OUTCOMES TOOL (MYPSYCKES) TO ASSESS MENTAL HEALTH PATIENTS' INTEREST IN ALTERNATIVE THERAPIES AND RELATED CONCERNS
• DEVELOPING AND EVALUATING A WEB-BASED PATIENT REPORTED OUTCOMES AND DECISION SUPPORT TOOL (MYPSYCKES)
• CONSUMER USABILITY TESTING OF A WEB-BASED PATIENT REPORTED OUTCOMES (PROS) AND DECISION SUPPORT TOOL (MYPSYCKES): IMPORTANT LESSONS FOR PROS SYSTEMS
• USING A WEB-BASED PATIENT REPORTED OUTCOMES PROGRAM (MYPSYCKES) TO EXAMINE PATIENT SMOKING STATUS AND INTEREST IN CESSATION SUPPORT
• DEVELOPING AND EVALUATING A WEB-BASED PATIENT REPORTED OUTCOMES AND DECISION SUPPORT TOOL (MYPSYCKES)
• CONSUMER USABILITY TESTING OF A WEB-BASED PATIENT REPORTED OUTCOMES (PROS) AND DECISION SUPPORT TOOL (MYPSYCKES): IMPORTANT LESSONS FOR PROS SYSTEMS
• USING A WEB-BASED PATIENT REPORTED OUTCOMES PROGRAM (MYPSYCKES) TO EXAMINE PATIENT SMOKING STATUS AND INTEREST IN CESSATION SUPPORT